Lv51
1250 积分 2024-02-21 加入
Antibody-Drug Conjugates (ADCs) for Breast Cancer Therapeutic Landscape: Concept and Mechanisms of Action
52分钟前
已关闭
Antibody-drug conjugates (ADCs): “Smart Missiles” targeting cancer therapy
1小时前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
1小时前
已完结
Computational studies of tyrosinase inhibitors
3个月前
已关闭
Azole inhibitors of mushroom and human tyrosinases: Current advances and prospects of drug development for melanogenic dermatological disorders
3个月前
已完结
Challenges and advances in atomistic simulations of potassium and sodium ion channel gating and permeation
3个月前
已完结
Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
4个月前
已完结
Role of Protein Kinases in Cellular Signaling
4个月前
已完结
Mechanisms of cutaneous toxicities to EGFR inhibitors
6个月前
已完结
Rational design of inhibitors that bind to inactive kinase conformations
6个月前
已关闭
皖公网安备34019202002308
